PMDA drug package insert
新カルシチュウD3
PMDA OTC drug · アリナミン製薬（株） · package insert Apr 20, 2021
Key facts
| Brand names | 新カルシチュウD3 |
|---|---|
| Companies | 製造販売元／日東薬品工業（株）,販売会社／アリナミン製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | カルシウム主薬製剤 |
| Package insert date | Apr 20, 2021 |
| PMDA document key | 530143_J0601005393 |
| PMDA company code | 530143 |
At a glance
- 10–99 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: